Form D · Other Health Care

Entia Biosciences, Inc.

Sherwood, OR · CIK 0001408299

Offering snapshot reported Dec 7, 2015 · SEC filing

Reported sold
$50K
Offering amount: $1M
Investors reported
1
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Nov 25, 2015
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 7, 2015Initial$50,000No comparison1SEC filing
May 26, 2015Amendment$495,000$290,000vs May 13, 201511SEC filing
May 13, 2015Initial$205,000No comparison8SEC filing
Jul 29, 2011Initial$207,500No comparison3SEC filing
Jun 15, 2009Initial$409,500No comparison9SEC filing
Oct 14, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-252521

Source: Form D, filed Dec 7, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Devin Duane Andres Executive
Frank Arnone Director, Executive
Marvin Stanley Hausman Director, Executive
Carl John Johnson Director, Executive
Elliot Louis Shelton Director
Elliott Shelton Director, Executive
Philip A Sobol Director
Phillip Sobol Director
Timothy Andrew Timmins Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
13565 Sw Tualatin Sherwood Road Suite 800
Sherwood, OR, 97140